US20150119933A1 - Anchoring device - Google Patents
Anchoring device Download PDFInfo
- Publication number
- US20150119933A1 US20150119933A1 US14/568,216 US201414568216A US2015119933A1 US 20150119933 A1 US20150119933 A1 US 20150119933A1 US 201414568216 A US201414568216 A US 201414568216A US 2015119933 A1 US2015119933 A1 US 2015119933A1
- Authority
- US
- United States
- Prior art keywords
- loop
- tissue
- anchoring
- suture
- medical device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0404—Buttons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0406—Pledgets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0412—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from suture anchor body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
- A61B2017/06176—Sutures with protrusions, e.g. barbs
Definitions
- the present disclosure relates generally to the field of surgical devices, and more particularly to anchoring devices, such as sutures, which include a loop having anchors disposed along a surface.
- Surgical sutures have been successfully used for various types of medical procedures, including tissue and wound closure.
- Surgical sutures typically have a needle attached at one end. As the needle penetrates tissue, the suture enters, passes through, and exits tissue, at which point knots may be used to secure the tissue or wound.
- sutures typically employ a knot at the distal end to secure the suture end in tissue, permitting movement of the free end through tissue. Knot tying adds time to a procedure and may result in additional bulk material being left at the wound site. Improvements in the field are desired.
- the present disclosure relates to methods for securing, and more specifically methods for securing tissue using anchoring devices.
- the method includes the steps of providing a suture having a proximal portion and a distal portion wherein the proximal portion includes an elongate body and the distal portion of the suture terminates in a loop, and at least a portion of the loop includes a plurality of barbs and the suture further includes a bifurcation of the elongate body into two branches.
- the method includes inserting the proximal portion of the suture into a tissue penetration point; advancing the two branches of the suture through the tissue such that the two branches are simultaneously pulled through a penetration point; and securing the suture in the tissue.
- the method may further include the step of inserting the proximal portion of the suture through a segment of the loop remaining outside the body tissue.
- the method may further include the step of pulling the suture through tissue until movement of the loop through tissue is limited by an end effector.
- the passage of the two branches of the loop through the penetration points may lead to an increase the holding force of the suture in tissue.
- the two branches also exert pressure on the tissue at the penetration point.
- the two branches of the anchoring device further includes barbs on a surface thereof and these barbs may secure the two branches in the body tissue.
- the anchoring device includes and end effector which limits movement of at least a portion of the loop through tissue such that a segment of the loop remains outside the body tissue.
- the end effector engages the tissue to prevent movement of the loop in a proximal direction.
- the present disclosure also contemplates an anchoring device having an elongate body including a proximal portion and a distal portion, the proximal portion of the elongate body terminating in a free end and the distal portion of the elongate body forming a loop; the loop includes a first plurality of anchors disposed along a surface of the loop and the loop further includes at least one end effector.
- the end effector is selected from the group consisting of barb, knot, pledget, and buttress.
- the end effector is a bulk of a material configured and dimensioned to limit movement of a distal segment of the loop in a proximal direction through tissue.
- the end effector may be integral with the loop, alternatively, the end effector may be a separate device which is secured to the loop.
- the end effector limits movement of at least a portion of the loop through tissue such that a segment of the loop remains outside a body tissue.
- the anchoring device of the present disclosure may further include a needle secured to a proximal portion of the elongate body.
- Another method for securing tissue comprises the steps of providing an anchoring device, inserting a proximal portion of the medical device into tissue, pulling the two branches of the loop through tissue such that the two branches are simultaneously pulled through a penetration point; and, advancing the proximal portion of the loop through tissue such that the end effector limits movement of the distal portion of the loop through the tissue.
- FIGS. 1A-1B are side views illustrating one embodiment of a looped suture
- FIGS. 2A-2B are side views illustrating another embodiment of a looped suture
- FIG. 3 is a side view illustrating one embodiment of an anchoring suture including barbs
- FIG. 3A is an enlarged view of the area of detail designated in FIG. 3 ;
- FIG. 4 is a side view illustrating an alternate embodiment of an anchoring suture including barbs
- FIG. 5 is an enlarged side view showing a barb of an alternate embodiment of an anchoring suture with a compound barb.
- FIG. 6 is a side view illustrating another embodiment of an anchoring suture including barbs
- FIG. 7 is a side view illustrating an alternate embodiment of an anchoring suture with an end effector
- FIG. 8A is a side view of another embodiment of an anchoring suture with an end effector
- FIG. 8B is a side view of a different embodiment of an anchoring suture with an end effector
- FIG. 8C is a side view of an alternate embodiment of an anchoring suture with an end effector
- FIG. 9A is a plan view of the anchoring suture of FIG. 4 in tissue with portions of tissue removed;
- FIG. 9B is a side view of the anchoring suture of FIG. 4 in tissue with portions of tissue removed;
- FIG. 10A is a plan view of the anchoring suture of FIG. 8C in a first position in tissue, with portions of tissue removed;
- FIG. 10B is a plan view of the anchoring suture of FIG. 8C in a second position in tissue, with portions of tissue removed;
- FIG. 11A shows a perspective view, partially in cross-section, of a suture filling a needle penetration point
- FIG. 11B shows a perspective view, partially in cross-section, of an anchoring suture of the present disclosure filling a needle penetration point.
- the present disclosure is directed to an anchoring device and in certain preferred embodiments, a suture, herein referred to as an anchoring suture.
- the anchoring sutures of certain embodiments of the present disclosure have an elongate body, which connects to a needle at a proximal end thereof, and a distal end of the elongate body forms an anchoring loop.
- the anchoring loop further includes a plurality of anchors (tissue engaging members).
- Medical devices of the present disclosure include sutures formed from fibers, filaments, and yarns.
- Anchoring devices including anchoring sutures of the present disclosure may be absorbable or non-absorbable. It should be understood that combinations of filaments made from different materials (e.g. natural and synthetic, or bioabsorbable and non-bioabsorbable materials) may be used to make the present anchoring suture.
- Suitable synthetic absorbable materials include polymers such as those made from lactide, glycolide, caprolactone, valerolactone, carbonates (e.g., trimethylene carbonate, tetramethylene carbonate), dioxanones (e.g., 1,4-dioxanone), 1,dioxepanones (e.g., 1,4-dioxepan-2-one and 1,5-dioxepan-2-one), ethylene glycol, ethylene oxide, esteramides, ⁇ -hydroxyvalerate, ⁇ -hydroxypropionate, alpha-hydroxy acid, hydroxybuterates, orthoesters, hydroxy alkanoates, tyrosine carbonates, polyimide carbonates, polyimino carbonates such as poly (bisphenol A-iminocarbonate) and poly (hydroquinone-iminocarbonate), and polymer drugs (e.g., polydiflunisol, polyaspirin, and protein therapeutics) and copolymers and combinations
- Suitable non-absorbable materials which may be used to form the anchoring sutures disclosed herein include non-absorbable natural materials such as cotton, silk, and rubber.
- Suitable non-absorbable synthetic materials include monomers and polymers derived from materials such as nylons, polyolefins such as polypropylene and polyethylene, ultra high molecular weight polyethylene (UHMWPE), polyamides, polyesters such as poly ethylene terephthalate (PET), polyaryletherketone, polyvinylidene difluoride (PVDF), acrylic, polyamides, aramids, fluropolymers, polybutesters, silicones, and polymer blends, copolymers thereof and combinations with degradable polymers.
- UHMWPE ultra high molecular weight polyethylene
- PVDF polyvinylidene difluoride
- Polypropylene can also be utilized to form the suture.
- the polypropylene can be isotactic polypropylene or a mixture of isotactic and syndiotactic or atactic polypropylene. Additionally, non-absorbable synthetic and natural polymers and monomers may be combined with each other and may also be combined with various absorbable polymers and monomers to create fibers and filaments for the present anchored device.
- anchoring devices including anchoring sutures, may, in whole or in part (e.g. anchors) may be constructed using shape memory polymers.
- Suitable polymers used to prepare hard and soft segments of shape memory polymers include polycaprolactone, dioxanone, lactide, glycolide, polyacrylates, polyamides, polysiloxanes, polyurethanes, polyether amides, polyurethane/ureas, polyether esters, and urethane/butadiene copolymers and combinations thereof.
- the sutures may include metals (e.g. steel and degradable magnesium), metal alloys or the like.
- fibers each may be used to construct in whole or in part anchoring devices.
- the term “fibers,” in this context, are generally used to designate natural or synthetic structures that have a length approximately 3 orders of magnitude greater than their diameter or width.
- the term “filaments” are typically used to describe “fibers” of indefinite or extreme length, and “yarns” as a generic term for a continuous strand of twisted or untwisted “fibers” or “filaments” in a form suitable for knitting, weaving, braiding or otherwise intertwining.
- Sutures of the present disclosure may be monofilament or multifilament (e.g. braided). Methods for making sutures from these suitable materials are within the purview of those skilled in the art (e.g. extrusion and molding).
- the filaments may be combined to create a multifilament suture using any technique within the purview of one skilled in the art such as commingling, twisting, braiding, weaving, entangling, and knitting.
- filaments may be combined to form a yarn or they may be braided.
- filaments may be combined to form a yarn and then those multifilament yarns may be braided.
- Fibers may also be combined to produce a non-woven multifilament large diameter suture.
- a multifilament structure useful in forming an anchoring suture according to the present disclosure may be produced by braiding.
- the braiding can be done by any method within the purview of those skilled in the art. For example, braid constructions for sutures and other medical devices are described in U.S. Pat. Nos.
- the anchoring device may include portions which are monofilament and portions which are multifilament.
- the proximal end of the elongate body may be a multifilament and the looped portion (loop portion described below) may be a monofilament.
- the anchoring device may include biologically acceptable additives such as plasticizers, antioxidants, dyes, dilutants, bioactive agents and combinations thereof, which can be coated on the filaments or fibers, or impregnated into the fibers or filaments (e.g. during compounding or extrusion) used to form the anchoring suture of the present disclosure.
- biologically acceptable additives such as plasticizers, antioxidants, dyes, dilutants, bioactive agents and combinations thereof, which can be coated on the filaments or fibers, or impregnated into the fibers or filaments (e.g. during compounding or extrusion) used to form the anchoring suture of the present disclosure.
- compositions and materials may also be applied to the anchoring sutures or included in the filaments or fibers to improve mechanical properties such as handling and knot strength or to deliver medicinal agents.
- Suitable coating materials include any materials conventionally applied to sutures.
- suitable materials include fatty acid esters which may be combined with the metal salt of a fatty acid in the coating composition.
- esters include, for example, calcium stearate, stearoyl lactylate esters, palmityl lactylate esters, oleyl lactylate esters such as calcium, magnesium, aluminum, barium, or zinc stearoyl lactylate, calcium, magnesium, aluminum, barium, or zinc palmityl lactylate; calcium, magnesium, aluminum, barium, or zinc oleyl lactylate; with calcium stearate and calcium stearoyl-2-lactylate (such as the calcium stearoyl-2-lactylate commercially available under the trade name VERV from American Ingredients Co., Kansas City, Mo.) being preferred.
- the fatty acid ester may be combined with a solvent.
- Suitable solvents include polar and non-polar solvents including but not limited to alcohols (e.g., methanol, ethanol, propanol), chlorinated hydrocarbons (such as methylene chloride, chloroform, 1,2-dichloro-ethane), and aliphatic hydrocarbons such as hexane, heptene, ethyl acetate.
- alcohols e.g., methanol, ethanol, propanol
- chlorinated hydrocarbons such as methylene chloride, chloroform, 1,2-dichloro-ethane
- aliphatic hydrocarbons such as hexane, heptene, ethyl acetate.
- the anchoring device may be combined with and/or coated with suitable materials including polyalkylene oxides such as polyethylene oxide, polypropylene oxide, polyethylene glycol (PEG), polypropylene glycol, copolymers thereof, and the like, including those having acrylate groups such as acrylate PEGs, and acrylate PEG/PPG copolymers.
- suitable materials including polyalkylene oxides such as polyethylene oxide, polypropylene oxide, polyethylene glycol (PEG), polypropylene glycol, copolymers thereof, and the like, including those having acrylate groups such as acrylate PEGs, and acrylate PEG/PPG copolymers.
- Such combinations may include blends or copolymers with polyalkylene oxide oligomers or polymers or other non-toxic surfactants.
- the resulting composition may possess antimicrobial properties due to the presence of the copolymers described above.
- the sutures may be combined with silicone acrylates. Coatings may be applied to the individual filaments or the
- the anchoring device may incorporate various pharmaceuticals and medicinal agents.
- Medicinal agents and drugs may be applied to the sutures and/or construct materials by methods within the purview of those skilled in the art, including but not limited to dipping, spraying, brushing, vapor deposition, coextrusion, capillary wicking, film casting, molding and the like.
- solvents may be used to incorporate various agents into the anchoring suture. Suitable solvent include those listed above.
- Medicinal agents which may be incorporated into the device include antimicrobial agents, anti-virals, anti-fungals, and the like.
- Antimicrobial agents as used herein is defined by an agent which by itself or through assisting the body (immune system) helps the body destroy or resist microorganisms which may be pathogenic (disease causing).
- the term “antimicrobial agent” includes antibiotics, quorum sensing blockers, surfactants, metal ions, antimicrobial proteins and peptides, antimicrobial polysaccharides, antiseptics, disinfectants, anti-virals, anti-fungals, and combinations thereof.
- Agents may be incorporated into a coating using solvents or mixed with various monomers or polymers and applied to the anchoring device.
- Additional suitable medicinal agents which may be used include colorants, dyes, preservatives, protein and peptide preparations, protein therapeutics, polysaccharides such as hyaluronic acid, lectins, lipids, probiotics, antibiotics, angiogenic agents, anti-thrombotics, anti-clotting agents, clotting agents, analgesics, anesthetics, wound repair agents, chemotherapeutics, biologics, anti-inflammatory agents, anti-proliferatives, diagnostic agents, antipyretic, antiphlogistic and analgesic agents, vasodilators, antihypertensive and antiarrhythmic agents, hypotensive agents, antitussive agents, antineoplastics, local anesthetics, hormone preparations, antiasthmatic and antiallergic agents, antihistaminics, anticoagulants, antispasmodics,
- polymer drugs i.e., polymeric forms of such compounds for example, polymeric antibiotics, polymeric antiseptics, polymeric chemotherapeutics, polymeric anti-proliferatives, polymeric antiseptics, polymeric non-steroidal anti-inflammatory drugs (NSAIDS), and the like may be utilized and combinations thereof.
- polymeric antibiotics i.e., polymeric antiseptics, polymeric chemotherapeutics, polymeric anti-proliferatives, polymeric antiseptics, polymeric non-steroidal anti-inflammatory drugs (NSAIDS), and the like
- NSAIDS polymeric non-steroidal anti-inflammatory drugs
- the anchoring device of the present disclosure can additionally contain suitable medicinal agents such as viruses and cells, peptides, polypeptides and proteins, analogs, muteins, and active fragments thereof, such as immunoglobulins, antibodies (monoclonal and polyclonal), cytokines (e.g.
- lymphokines monokines, chemokines
- blood clotting factors hemopoietic factors, interleukins (IL-2, IL-3, IL-4, IL-6), interferons ( ⁇ -IFN, ⁇ -IFN and ⁇ -IFN), erythropoietin, nucleases, tumor necrosis factor, colony stimulating factors (e.g., GCSF, GM-CSF, MCSF), insulin, anti-tumor agents and tumor suppressors, blood proteins, gonadotropins (e.g., FSH, LH, CG, etc.) hormones and hormone analogs (e.g., growth hormone), vaccines (e.g., tumoral, bacterial and viral antigens), somatostatin, antigens, blood coagulation factors, growth factors, protein inhibitors, protein antagonists, and protein agonists, nucleic acids, such as antisense molecules, DNA, RNA, oligonucleotides, polynucleotides and
- compositions of the present disclosure are within the purview of those skilled in the art and include, but are not limited to mixing, blending, dipping, spraying, wicking, solvent evaporating and the like.
- proximal means the portion of the device which is nearer to the user, while the term “distal” refers to the portion of the device which is further away from the user.
- Sutures of the present disclosure include an elongate body, having both distal and proximal portions, the distal portion of which transitions from the elongate body to an anchoring loop.
- Methods for creating anchoring loops are within the purview of those skilled in the art and include but are not limited to welding, ultrasonic energy, cutting, molding and gluing.
- the anchoring loop includes barbs along a surface.
- Adjuncts to making loops may also be employed in the anchoring suture.
- the distal portion of suture may be folded and fixed to elongate body using adhesives and glues.
- loop portion may initially be a separate component which connects to an elongate body and optionally glued in place. It should be understood that embodiments and methods described in FIGS. 1 and 2 can be used to create any of the anchoring suture embodiments described herein ( FIGS. 3-6 ).
- Suitable materials such as absorbable and non-absorbable materials include, but not limited to cyanoacrylates, isocyanates, polyurethanes, polyamines, polyamides, polyacrylates, polymethacrylates, silicones, carbonates, and other synthetic monomers and polymers and combinations thereof.
- Adhesives such as cyanoacrylates can be employed in creating sutures of the present disclosure.
- Suitable cyanoacrylates include materials derived from methyl cyanoacrylate, ethyl cyanoacrylate, butyl cyanoacrylate, octyl cyanoacrylate, isobutyl cyanoacrylate, and methoxypropyl cyanoacrylate and combinations thereof and the like.
- the anchoring loop further includes anchors disposed along a surface.
- Anchors can be created on the anchoring suture using any technique, including but not limited to lasers, molding, knives, blades, stamping, and other cutting means within the purview of those skilled in the art. Ultrasonic energy can also be used to create barbs or anchors as described in U.S. Patent Application No. 60/994,173 filed on Sep. 17, 2007 entitled “Method of Forming Barbs on a Suture” the entire disclosures of which are incorporated by reference herein.
- anchoring sutures of the present disclosure include loops which are integral to an elongate body, as shown in FIGS. 1 and 3 .
- Sutures with integral loops may be defined as having one structure or component in which the elongate body is continuous with the loop.
- FIG. 1 shows an elongate body 10 in which the distal end is folded or “looped” to create a loop 14 ( FIG. 1B ) at the distal end of the medical device.
- the suture as shown in FIGS. 1 and 2 further includes transition area 16 and anchors which will be described in further detail below.
- An anchoring suture may also contain an integral loop as shown in FIG. 3 , wherein the loop portion may be molded. In alternate embodiments, such as FIG.
- anchoring sutures may comprise two components which are fixed or fitted together in a fashion as to create the anchoring suture.
- the elongate body 10 may include a female component while the loop 14 may include a male component and the two components may be fitted together to create a final product.
- One skilled in the art can envision other manufacturing processes in which to create integral loops and medical devices with integral and non-integral loops.
- FIG. 3 Another embodiment of the anchoring suture of the present disclosure is shown in FIG. 3 and is designated generally by reference numeral 2 .
- Suture 2 has an elongate body 10 , a proximal portion of elongate body 10 terminating in a free end 11 , and a distal portion of the elongate body 10 which forms, transitions into, or terminates in a loop 14 .
- the free end 11 further comprises a needle 12 .
- the elongate body 10 has a diameter “x” and, in preferred embodiments, the elongate body 10 is generally elliptical in transverse cross-section.
- the distal end of elongate body 10 extends into a loop 14 , bifurcating at transition area 16 ( FIGS.
- Loop 14 includes two branches 14 a and 14 b , which may be identical in shape and cross-sectional area, to both each other and elongate body 10 .
- sections 14 a and 14 b are generally elliptical in shape and cross-sectional area, although other shapes are envisioned such as circular, oval, square, and rectangular.
- the loop 14 may be integral with the elongate body 10 of the suture 2 .
- the loop 14 may be a separate component prior to assembly ( FIGS. 1 and 2 ), and during assembly the loop 14 may be attached to the elongate body 10 .
- the loop 14 has a generally arcuate surface, and each branch ( 14 a and 14 b ) has an independent diameter “y”, of which 14 a and 14 b may be of similar or different diameters.
- the loop may be of any shape including circular, oval, polygonal.
- anchoring suture of FIG. 3 includes a first plurality of anchors 18 disposed along a surface of the loop 14 .
- Anchors 18 a are disposed along surface of branch 14 a and anchors 18 b are disposed along branch 14 b .
- segment 14 c is used to designate a loop segment in which barbs are absent.
- anchors 18 are located adjacent transition area 16 of elongate body 10 and anchoring loop 14 .
- the first plurality of anchors 18 is oriented such that movement of the anchoring loop 14 towards the proximal end is limited. As shown in FIG. 3 , anchors 18 are oriented towards transition area 16 to prevent movement of anchoring loop 14 through tissue. In embodiments shown, anchors 18 are integral to the anchoring loop 14 .
- FIG. 4 is a generally similar to FIG. 3 and therefore all numerals and descriptions which are the same in FIG. 3 are designated with the prime mark and have some differences.
- FIG. 4 shows an alternate embodiment of an anchoring suture 2 ′ in which a second plurality of anchors 22 is disposed along the elongate body 10 ′.
- the second plurality of anchors 22 extends in the second direction which is different from a first direction of the first plurality of anchors.
- the first plurality of anchors 18 ′ are disposed along a loop surface and extend in the first direction, generally towards transition area 16 ′ of the anchoring suture 2 ′.
- the second plurality of anchors 22 extend in a second direction, towards the loop 14 ′, with respect to longitudinal axis A of the elongate body 10 . As shown in FIG. 4 . the first plurality of anchors 18 ′ and the second plurality of anchors 22 extend in directions substantially opposite to one another. The second plurality of anchors 22 permits movement of the elongate body 10 ′ in the direction of the leading or proximal end while preventing movement of the elongate body 10 ′ towards the loop end.
- anchoring suture 30 includes a compound barb 26 having an inner surface 30 including a first angle ⁇ , disposed at a first orientation relative to a longitudinal axis “A′” of the elongate body and a second angle ⁇ having a second inner surface 32 , disposed at a second orientation relative to a longitudinal axis b of the elongate body.
- the anchoring suture may optionally include a third orientation (not shown).
- the first, second and third orientations are each disposed at different angles with respect to the longitudinal axis.
- the anchoring suture may include a staggered arrangement of large or small barbs.
- an anchoring suture may have a random configuration of both large and small barbs. It will be understood that the embodiment shown in FIG. 5 is generally similar to FIGS. 3 and 4 , but has a different geometry for the barbs. In alternate embodiments, the above-mentioned compound barb geometry may also be present on the anchoring loop (not shown).
- the surface area of the plurality of anchors can also vary.
- fuller-tipped anchors can be made of varying sizes designed for specific surgical applications. When joining fat and relatively soft tissues, larger anchors may be desired, whereas smaller anchors may be more suitable for collagen-dense tissues.
- a combination of large and small anchors within the same structure may be beneficial, for example when a fiber is used in tissue repair with differing layer structures. Use of the combination of large and small anchors with the same fiber wherein anchor sizes are customized for each tissue layer will ensure maximum holding properties.
- FIG. 6 Another embodiment of an anchoring device is shown in FIG. 6 .
- the anchoring device 40 includes a needle 42 at a proximal end 41 of the device.
- the device bifurcates at a transition area 45 , and a distal portion of the device terminates in an anchoring loop 49 .
- the anchoring loop 49 includes two branches 46 a and 46 b at a proximal end 47 of the anchoring loop 49 .
- the anchoring loop 49 has a generally arcuate surface, branches 46 a and 46 b may have similar or different diameters.
- a first plurality of anchors 48 are located adjacent the transition area 45 .
- the first plurality of anchors 48 is oriented such that movement of the anchoring loop 49 in tissue, in a direction towards the distal end 43 of the device, is limited.
- the device may have an elongate body 44 that is shorter in longitudinal length as compared to the anchoring loop 49 .
- the two branches of the loop may be advanced through a single needle penetration point and pulled through tissue; the method of which will be described in detail later.
- FIG. 7 illustrates an alternate embodiment of an anchoring device 50 which may be used in combination with a mechanical suturing device such as an Endo StitchTM suturing device commercially available from Tyco Healthcare Group LP.
- Anchoring device 50 includes a needle 52 which is compatible with a mechanical suturing device such as an Endo StitchTM suturing device.
- the proximal portion 51 of the anchoring suture includes an elongate body 54 , and the distal portion 55 of the suture terminates in a loop 59 .
- the loop 59 includes two branches 56 a and 56 b and each branch includes a plurality of barbs 58 on a surface thereof.
- a plurality of barbs may only be on a surface of at least one branch or a portion of the anchoring device.
- the loop 59 also includes an unbarbed distal portion 56 c .
- the loop further includes an end effector 57 which limits movement of the anchoring device through tissue.
- the end effector is located on the unbarbed distal portion 56 c of the loop ( FIG. 7 ).
- the end effector 57 is a bulk (large mass) of suture material, which is generally “T”-shaped and in the current embodiment, the end effector is welded to the loop 59 .
- FIGS. 8A , 8 B and 8 C This disclosure contemplates different end effectors and non-limiting alternate embodiments are illustrated in FIGS. 8A , 8 B and 8 C.
- an end effector is illustrated as a second plurality of barbs 60 which are oriented such that movement of an end portion of the loop 63 through tissue towards a proximal end of the anchoring suture is limited.
- a first plurality of barbs 62 located at a proximal portion of the loop 63 are shown oriented in a generally opposite direction to a second plurality of barbs 60 , which are located at a distal portion of loop 63 .
- the end effector is a bead 65 of a polymeric material.
- the bead may of a similar material to the anchoring loop and in alternate embodiments; the bead may be comprised of a different material than the anchoring loop.
- the end effector is integral with the loop.
- the end effector may be a separate device such as a pledget or buttress.
- the end effector is a pledget 67 formed on or otherwise attached to the loop. In this embodiment, prior to creating a loop, a suture may penetrate the pledget 67 and a length of the suture may be pulled through the pledget.
- a loop may be created via various means including those described above, and the pledget 67 may be positioned at a distal most point of the anchoring loop.
- end effectors are not limited to those structures described herein and one skilled in the art may contemplate other shapes and devices which may be used for a similar purpose. End effectors may be constructed using methods within the purview of those skilled in the art, including but not limited to glues, adhesives, lasers, ultrasonic or heat welding, molding, overmolding and the like. Any of the suture materials and structures discussed above may be used to form the anchoring devices discussed herein.
- tissue includes, but is not limited to, tissues such as skin, fat, fascia, bones, muscles, tendons, ligaments, organs, nerves, and blood vessels.
- wound includes, but is not limited to, a surgical incision, cut, laceration or severed tissue in human or animal skin or other human or animal bodily tissue.
- Tissue may be sutured by inserting proximal portion of an anchoring suture into tissue at a first section and advancing the proximal portion of the suture through a second section of the tissue, and exiting tissue at an exit point.
- the suture is pulled through the exit point until the first plurality of barbs on the anchoring loop engages tissue and resists movement in direction of needle advancement, thus preventing further advancement of anchoring loop through tissue.
- the proximal portion of the suture may optionally be inserted through the segment of the loop remaining outside the body tissue for enhanced fixation.
- FIGS. 9A and 9B show the embodiment of FIG.
- FIGS. 10A and 10B illustrate the embodiment of FIG. 8C in tissue.
- Tissue may be secured in a similar manner as described above, by inserting a proximal portion of the anchoring device into tissue at a first section and advancing the proximal portion of the anchoring device, including a proximal portion of the loop, through a second section of the tissue, and exiting tissue at an exit point.
- the remainder of the suture follows including the two branches of the loop. More specifically, the two branches of the loop are advanced through a needle penetration point (or points through which the needle and elongate body have passed).
- FIG. 10A illustrates a first position of the embodiment of an anchoring device as described in FIG. 8C .
- proximal portion of suture 70 and proximal portion 71 of loop 72 are advanced through tissue.
- Both branches 72 a and 72 b are advanced through needle penetration points ( 74 a , 74 b , 74 c , and 74 d ), the barbs engage tissue and suture holding force is increased.
- FIG. 10B shows the embodiment of FIG. 8C in a second position. Once the anchoring suture has been further advanced through tissue, the pledget 67 prevents any further movement of the distal loop portion through tissue.
- end effectors and shown and described would function in a manner similar to the embodiment described with respect to FIGS. 10A and 10B . It should also be understood that anchoring sutures without end effectors may also be inserted and advanced through tissue in a similar manner.
- FIG. 11A shows the prior art in which an oversized needle 80 penetrates tissue, and leaves a tissue penetration point ( 82 a and 82 b ) that a single suture strand 84 may not fill.
- FIG. 11B shows one embodiment of the current disclosure in which an oversized needle 90 penetrates tissue and the two branches ( 94 a and 94 b ) of the anchoring device 94 can better fill the needle penetration point 92 .
- the two branches of the loop in combination with the barbs allow an increase in tissue holding strength which may be desirable in certain applications.
- a needle attachment can be made by any conventional method such as crimping, swaging, etc, as is known within the purview of those skilled in the art.
- a reduced diameter may be provided at the end of the suture to be inserted into the drilled end of a needle.
- the suture may by machined using any technique within the purview of those skilled in the art, such as cutting, grinding, laser machining or the like.
- Anchoring devices including anchoring sutures of the present disclosure may be employed in medical devices, drug delivery devices and cell growth substrates.
- suitable medical devices and/or surgical devices employing the anchoring sutures may include, but are not limited to meshes, wound dressings, bandages, drug delivery devices, anastomosis rings, stents, grafts, catheter systems, soft tissue repair and augmentation devices, scaffolds, buttresses, lap bands, tapes, anchors, ribbons, orthopedic devices, tissue engineering scaffolds, various cell growth substrates, and other implantable devices.
- devices of the present disclosure may be knitted or woven with other fibers, either absorbable or non-absorbable, to form surgical devices.
- the anchoring devices and/or sutures also can be made into meshes or non-woven materials to form fabrics, such as matted fabrics and felts.
- anchoring devices of the present disclosure may be packaged using materials known to those within the purview of those skilled in the art, including foil and various plastics (e.g. polyethylene), which may provide a moisture barrier.
- the anchoring device can be sterilized by any means within the purview of those skilled in the art including but not limited to ethylene oxide, electron beam (e-beam), gamma irradiation, autoclaving, and the like.
- MaxonTM suture Distal end of MaxonTM suture is folded towards elongate body to create a loop, and suture (loop) is then placed in an ultrasonic welding apparatus, where loop is welded closed. Suture is then affixed to an ultrasonic cutting apparatus to create barbs. Elongate body and anchoring loop of anchoring suture is cut via ultrasonic blades at various angles.
- Distal end of SurgiproTM suture is folded towards elongate body to create loop and glue is placed on elongate body and distal suture end is folded over and attached to elongate body, creating a fixed loop.
- Suture is then affixed to a cutting apparatus and anchoring suture is cut at various angles using a knife.
- Anchoring suture is then coated with a chemotherapeutic agent using solvent casting.
- Distal end of MaxonTM suture is folded towards elongate body to create a loop, and suture (loop) is then placed in an ultrasonic welding apparatus, where loop is welded closed.
- the ultrasonic welding apparatus is then used to weld a distal end of the loop into a generally “T”-shape, creating an end effector.
- Suture is next affixed to an ultrasonic cutting apparatus to create barbs. Elongate body and a proximal portion of the anchoring loop of anchoring suture is cut via ultrasonic blades at various angles.
Abstract
An anchoring device having an elongate body at a proximal portion, a distal portion of the elongate body forming a loop at a distal portion of the anchoring device. The loop further includes a plurality of anchors disposed along a surface thereof and the loop also including an end effector. Methods for securing anchoring devices of the present disclosure are also disclosed.
Description
- This application is a divisional of U.S. patent application Ser. No. 12/416,421 filed Apr. 1, 2009, which is a continuation in part of U.S. patent application Ser. No. 12/362,002 filed Jan. 29, 2009, which claims benefit of U.S. Provisional Application No. 61/041,302 filed Apr. 1, 2008, and the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.
- The present disclosure relates generally to the field of surgical devices, and more particularly to anchoring devices, such as sutures, which include a loop having anchors disposed along a surface.
- Surgical sutures have been successfully used for various types of medical procedures, including tissue and wound closure. Surgical sutures typically have a needle attached at one end. As the needle penetrates tissue, the suture enters, passes through, and exits tissue, at which point knots may be used to secure the tissue or wound.
- Additionally, sutures typically employ a knot at the distal end to secure the suture end in tissue, permitting movement of the free end through tissue. Knot tying adds time to a procedure and may result in additional bulk material being left at the wound site. Improvements in the field are desired.
- Furthermore, specific patient populations such as patients with diabetes T1, T2, or other immuno-compromised patients (such as chemotherapy patients) have less elastic tissue. These patient populations have longer healing profiles and less compliant tissue and these factors may lead to lower suture holding forces in tissue. Needles tend to be oversized for given suture diameter and a larger needle may leave behind a larger hole at the needle penetration point in the tissue. The suture generally needs to fill this hole. Also, improvements in suture holding forces are desired.
- The present disclosure relates to methods for securing, and more specifically methods for securing tissue using anchoring devices. The method includes the steps of providing a suture having a proximal portion and a distal portion wherein the proximal portion includes an elongate body and the distal portion of the suture terminates in a loop, and at least a portion of the loop includes a plurality of barbs and the suture further includes a bifurcation of the elongate body into two branches. The method includes inserting the proximal portion of the suture into a tissue penetration point; advancing the two branches of the suture through the tissue such that the two branches are simultaneously pulled through a penetration point; and securing the suture in the tissue. The method may further include the step of inserting the proximal portion of the suture through a segment of the loop remaining outside the body tissue. The method may further include the step of pulling the suture through tissue until movement of the loop through tissue is limited by an end effector.
- Additionally, the passage of the two branches of the loop through the penetration points may lead to an increase the holding force of the suture in tissue. The two branches also exert pressure on the tissue at the penetration point. The two branches of the anchoring device further includes barbs on a surface thereof and these barbs may secure the two branches in the body tissue.
- In some embodiments, the anchoring device includes and end effector which limits movement of at least a portion of the loop through tissue such that a segment of the loop remains outside the body tissue. In certain embodiments, the end effector engages the tissue to prevent movement of the loop in a proximal direction.
- The present disclosure also contemplates an anchoring device having an elongate body including a proximal portion and a distal portion, the proximal portion of the elongate body terminating in a free end and the distal portion of the elongate body forming a loop; the loop includes a first plurality of anchors disposed along a surface of the loop and the loop further includes at least one end effector.
- In certain embodiments the end effector is selected from the group consisting of barb, knot, pledget, and buttress. In other embodiments the end effector is a bulk of a material configured and dimensioned to limit movement of a distal segment of the loop in a proximal direction through tissue. In some embodiments, the end effector may be integral with the loop, alternatively, the end effector may be a separate device which is secured to the loop. In alternate embodiments, the end effector limits movement of at least a portion of the loop through tissue such that a segment of the loop remains outside a body tissue.
- The anchoring device of the present disclosure may further include a needle secured to a proximal portion of the elongate body.
- Another method for securing tissue is also provided, the method comprises the steps of providing an anchoring device, inserting a proximal portion of the medical device into tissue, pulling the two branches of the loop through tissue such that the two branches are simultaneously pulled through a penetration point; and, advancing the proximal portion of the loop through tissue such that the end effector limits movement of the distal portion of the loop through the tissue.
- Various preferred embodiments of the sutures are described herein with reference to the drawings, in which:
-
FIGS. 1A-1B are side views illustrating one embodiment of a looped suture; -
FIGS. 2A-2B are side views illustrating another embodiment of a looped suture; -
FIG. 3 is a side view illustrating one embodiment of an anchoring suture including barbs; -
FIG. 3A is an enlarged view of the area of detail designated inFIG. 3 ; -
FIG. 4 is a side view illustrating an alternate embodiment of an anchoring suture including barbs; -
FIG. 5 is an enlarged side view showing a barb of an alternate embodiment of an anchoring suture with a compound barb; and, -
FIG. 6 is a side view illustrating another embodiment of an anchoring suture including barbs; -
FIG. 7 is a side view illustrating an alternate embodiment of an anchoring suture with an end effector; -
FIG. 8A is a side view of another embodiment of an anchoring suture with an end effector; -
FIG. 8B is a side view of a different embodiment of an anchoring suture with an end effector; -
FIG. 8C is a side view of an alternate embodiment of an anchoring suture with an end effector; -
FIG. 9A is a plan view of the anchoring suture ofFIG. 4 in tissue with portions of tissue removed; -
FIG. 9B is a side view of the anchoring suture ofFIG. 4 in tissue with portions of tissue removed; -
FIG. 10A is a plan view of the anchoring suture ofFIG. 8C in a first position in tissue, with portions of tissue removed; -
FIG. 10B is a plan view of the anchoring suture ofFIG. 8C in a second position in tissue, with portions of tissue removed; -
FIG. 11A shows a perspective view, partially in cross-section, of a suture filling a needle penetration point; and, -
FIG. 11B shows a perspective view, partially in cross-section, of an anchoring suture of the present disclosure filling a needle penetration point. - The present disclosure is directed to an anchoring device and in certain preferred embodiments, a suture, herein referred to as an anchoring suture. The anchoring sutures of certain embodiments of the present disclosure have an elongate body, which connects to a needle at a proximal end thereof, and a distal end of the elongate body forms an anchoring loop. The anchoring loop further includes a plurality of anchors (tissue engaging members). Medical devices of the present disclosure include sutures formed from fibers, filaments, and yarns.
- Anchoring devices, including anchoring sutures of the present disclosure may be absorbable or non-absorbable. It should be understood that combinations of filaments made from different materials (e.g. natural and synthetic, or bioabsorbable and non-bioabsorbable materials) may be used to make the present anchoring suture.
- Suitable synthetic absorbable materials include polymers such as those made from lactide, glycolide, caprolactone, valerolactone, carbonates (e.g., trimethylene carbonate, tetramethylene carbonate), dioxanones (e.g., 1,4-dioxanone), 1,dioxepanones (e.g., 1,4-dioxepan-2-one and 1,5-dioxepan-2-one), ethylene glycol, ethylene oxide, esteramides, γ-hydroxyvalerate, β-hydroxypropionate, alpha-hydroxy acid, hydroxybuterates, orthoesters, hydroxy alkanoates, tyrosine carbonates, polyimide carbonates, polyimino carbonates such as poly (bisphenol A-iminocarbonate) and poly (hydroquinone-iminocarbonate), and polymer drugs (e.g., polydiflunisol, polyaspirin, and protein therapeutics) and copolymers and combinations thereof. Suitable natural absorbable polymers include collagen, cellulose and gut. In embodiments, glycolide and lactide based polyesters, including copolymers of lactide and glycolide may be used.
- Suitable non-absorbable materials which may be used to form the anchoring sutures disclosed herein include non-absorbable natural materials such as cotton, silk, and rubber. Suitable non-absorbable synthetic materials include monomers and polymers derived from materials such as nylons, polyolefins such as polypropylene and polyethylene, ultra high molecular weight polyethylene (UHMWPE), polyamides, polyesters such as poly ethylene terephthalate (PET), polyaryletherketone, polyvinylidene difluoride (PVDF), acrylic, polyamides, aramids, fluropolymers, polybutesters, silicones, and polymer blends, copolymers thereof and combinations with degradable polymers. Polypropylene can also be utilized to form the suture. The polypropylene can be isotactic polypropylene or a mixture of isotactic and syndiotactic or atactic polypropylene. Additionally, non-absorbable synthetic and natural polymers and monomers may be combined with each other and may also be combined with various absorbable polymers and monomers to create fibers and filaments for the present anchored device.
- In certain embodiments, anchoring devices, including anchoring sutures, may, in whole or in part (e.g. anchors) may be constructed using shape memory polymers. Suitable polymers used to prepare hard and soft segments of shape memory polymers include polycaprolactone, dioxanone, lactide, glycolide, polyacrylates, polyamides, polysiloxanes, polyurethanes, polyether amides, polyurethane/ureas, polyether esters, and urethane/butadiene copolymers and combinations thereof.
- In some embodiments, the sutures may include metals (e.g. steel and degradable magnesium), metal alloys or the like.
- As used herein, the terms “fibers”, “filaments” and “yarns” each may be used to construct in whole or in part anchoring devices. The term “fibers,” in this context, are generally used to designate natural or synthetic structures that have a length approximately 3 orders of magnitude greater than their diameter or width. The term “filaments” are typically used to describe “fibers” of indefinite or extreme length, and “yarns” as a generic term for a continuous strand of twisted or untwisted “fibers” or “filaments” in a form suitable for knitting, weaving, braiding or otherwise intertwining.
- Sutures of the present disclosure may be monofilament or multifilament (e.g. braided). Methods for making sutures from these suitable materials are within the purview of those skilled in the art (e.g. extrusion and molding). The filaments may be combined to create a multifilament suture using any technique within the purview of one skilled in the art such as commingling, twisting, braiding, weaving, entangling, and knitting. For example, filaments may be combined to form a yarn or they may be braided. In another example, filaments may be combined to form a yarn and then those multifilament yarns may be braided. Those skilled in the art reading this disclosure will envision other ways in which filaments may be combined. Fibers may also be combined to produce a non-woven multifilament large diameter suture. In certain embodiments, a multifilament structure useful in forming an anchoring suture according to the present disclosure may be produced by braiding. The braiding can be done by any method within the purview of those skilled in the art. For example, braid constructions for sutures and other medical devices are described in U.S. Pat. Nos. 5,019,093; 5,059,213; 5,133,738; 5,181,923; 5,226,912; 5,261,886; 5,306,289; 5,318,575; 5,370,031; 5,383,387; 5,662,682; 5,667,528; and 6,203,564; the entire disclosures of each of which are incorporated by reference herein. Furthermore, the anchoring device may include portions which are monofilament and portions which are multifilament. In some embodiments, the proximal end of the elongate body may be a multifilament and the looped portion (loop portion described below) may be a monofilament.
- Additionally, the anchoring device may include biologically acceptable additives such as plasticizers, antioxidants, dyes, dilutants, bioactive agents and combinations thereof, which can be coated on the filaments or fibers, or impregnated into the fibers or filaments (e.g. during compounding or extrusion) used to form the anchoring suture of the present disclosure.
- Various compositions and materials may also be applied to the anchoring sutures or included in the filaments or fibers to improve mechanical properties such as handling and knot strength or to deliver medicinal agents. Suitable coating materials include any materials conventionally applied to sutures. For example, suitable materials include fatty acid esters which may be combined with the metal salt of a fatty acid in the coating composition. Such esters include, for example, calcium stearate, stearoyl lactylate esters, palmityl lactylate esters, oleyl lactylate esters such as calcium, magnesium, aluminum, barium, or zinc stearoyl lactylate, calcium, magnesium, aluminum, barium, or zinc palmityl lactylate; calcium, magnesium, aluminum, barium, or zinc oleyl lactylate; with calcium stearate and calcium stearoyl-2-lactylate (such as the calcium stearoyl-2-lactylate commercially available under the trade name VERV from American Ingredients Co., Kansas City, Mo.) being preferred. When desirable, the fatty acid ester may be combined with a solvent. Suitable solvents include polar and non-polar solvents including but not limited to alcohols (e.g., methanol, ethanol, propanol), chlorinated hydrocarbons (such as methylene chloride, chloroform, 1,2-dichloro-ethane), and aliphatic hydrocarbons such as hexane, heptene, ethyl acetate.
- In embodiments, the anchoring device may be combined with and/or coated with suitable materials including polyalkylene oxides such as polyethylene oxide, polypropylene oxide, polyethylene glycol (PEG), polypropylene glycol, copolymers thereof, and the like, including those having acrylate groups such as acrylate PEGs, and acrylate PEG/PPG copolymers. Such combinations may include blends or copolymers with polyalkylene oxide oligomers or polymers or other non-toxic surfactants. The resulting composition may possess antimicrobial properties due to the presence of the copolymers described above. In other embodiments, the sutures may be combined with silicone acrylates. Coatings may be applied to the individual filaments or the anchoring suture at any time prior to sterilization techniques. Coatings can be applied to the filaments using any technique within the purview of those skilled in the art.
- Additionally, the anchoring device may incorporate various pharmaceuticals and medicinal agents. Medicinal agents and drugs may be applied to the sutures and/or construct materials by methods within the purview of those skilled in the art, including but not limited to dipping, spraying, brushing, vapor deposition, coextrusion, capillary wicking, film casting, molding and the like. Additionally, solvents may be used to incorporate various agents into the anchoring suture. Suitable solvent include those listed above.
- Medicinal agents which may be incorporated into the device include antimicrobial agents, anti-virals, anti-fungals, and the like. Antimicrobial agents as used herein is defined by an agent which by itself or through assisting the body (immune system) helps the body destroy or resist microorganisms which may be pathogenic (disease causing). The term “antimicrobial agent” includes antibiotics, quorum sensing blockers, surfactants, metal ions, antimicrobial proteins and peptides, antimicrobial polysaccharides, antiseptics, disinfectants, anti-virals, anti-fungals, and combinations thereof.
- Agents may be incorporated into a coating using solvents or mixed with various monomers or polymers and applied to the anchoring device. Additional suitable medicinal agents which may be used include colorants, dyes, preservatives, protein and peptide preparations, protein therapeutics, polysaccharides such as hyaluronic acid, lectins, lipids, probiotics, antibiotics, angiogenic agents, anti-thrombotics, anti-clotting agents, clotting agents, analgesics, anesthetics, wound repair agents, chemotherapeutics, biologics, anti-inflammatory agents, anti-proliferatives, diagnostic agents, antipyretic, antiphlogistic and analgesic agents, vasodilators, antihypertensive and antiarrhythmic agents, hypotensive agents, antitussive agents, antineoplastics, local anesthetics, hormone preparations, antiasthmatic and antiallergic agents, antihistaminics, anticoagulants, antispasmodics, cerebral circulation and metabolism improvers, antidepressant and antianxiety agents, vitamin D preparations, hypoglycemic agents, antiulcer agents, hypnotics, antibiotics, antifungal agents, sedative agents, bronchodilator agents, antiviral agents, dysuric agents, brominated or halogenated furanones, and the like. In embodiments, polymer drugs, i.e., polymeric forms of such compounds for example, polymeric antibiotics, polymeric antiseptics, polymeric chemotherapeutics, polymeric anti-proliferatives, polymeric antiseptics, polymeric non-steroidal anti-inflammatory drugs (NSAIDS), and the like may be utilized and combinations thereof.
- The anchoring device of the present disclosure can additionally contain suitable medicinal agents such as viruses and cells, peptides, polypeptides and proteins, analogs, muteins, and active fragments thereof, such as immunoglobulins, antibodies (monoclonal and polyclonal), cytokines (e.g. lymphokines, monokines, chemokines), blood clotting factors, hemopoietic factors, interleukins (IL-2, IL-3, IL-4, IL-6), interferons (β-IFN, α-IFN and γ-IFN), erythropoietin, nucleases, tumor necrosis factor, colony stimulating factors (e.g., GCSF, GM-CSF, MCSF), insulin, anti-tumor agents and tumor suppressors, blood proteins, gonadotropins (e.g., FSH, LH, CG, etc.) hormones and hormone analogs (e.g., growth hormone), vaccines (e.g., tumoral, bacterial and viral antigens), somatostatin, antigens, blood coagulation factors, growth factors, protein inhibitors, protein antagonists, and protein agonists, nucleic acids, such as antisense molecules, DNA, RNA, oligonucleotides, polynucleotides and ribozymes and combinations thereof.
- Methods for combining these medicinal agents with compositions of the present disclosure are within the purview of those skilled in the art and include, but are not limited to mixing, blending, dipping, spraying, wicking, solvent evaporating and the like.
- In the description that follows, the term “proximal” as used herein, means the portion of the device which is nearer to the user, while the term “distal” refers to the portion of the device which is further away from the user.
- Sutures of the present disclosure include an elongate body, having both distal and proximal portions, the distal portion of which transitions from the elongate body to an anchoring loop. Methods for creating anchoring loops are within the purview of those skilled in the art and include but are not limited to welding, ultrasonic energy, cutting, molding and gluing. In preferred embodiments to be described later, the anchoring loop includes barbs along a surface.
- Adjuncts to making loops, such as adhesives and glues, may also be employed in the anchoring suture. In some embodiments (
FIGS. 1A , 1B), the distal portion of suture may be folded and fixed to elongate body using adhesives and glues. In alternate embodiments, as shown inFIGS. 2A and 2B , loop portion may initially be a separate component which connects to an elongate body and optionally glued in place. It should be understood that embodiments and methods described inFIGS. 1 and 2 can be used to create any of the anchoring suture embodiments described herein (FIGS. 3-6 ). Suitable materials such as absorbable and non-absorbable materials include, but not limited to cyanoacrylates, isocyanates, polyurethanes, polyamines, polyamides, polyacrylates, polymethacrylates, silicones, carbonates, and other synthetic monomers and polymers and combinations thereof. - Adhesives such as cyanoacrylates can be employed in creating sutures of the present disclosure. Suitable cyanoacrylates include materials derived from methyl cyanoacrylate, ethyl cyanoacrylate, butyl cyanoacrylate, octyl cyanoacrylate, isobutyl cyanoacrylate, and methoxypropyl cyanoacrylate and combinations thereof and the like.
- The anchoring loop further includes anchors disposed along a surface. Anchors can be created on the anchoring suture using any technique, including but not limited to lasers, molding, knives, blades, stamping, and other cutting means within the purview of those skilled in the art. Ultrasonic energy can also be used to create barbs or anchors as described in U.S. Patent Application No. 60/994,173 filed on Sep. 17, 2007 entitled “Method of Forming Barbs on a Suture” the entire disclosures of which are incorporated by reference herein.
- In some embodiments, anchoring sutures of the present disclosure include loops which are integral to an elongate body, as shown in
FIGS. 1 and 3 . Sutures with integral loops may be defined as having one structure or component in which the elongate body is continuous with the loop. For example,FIG. 1 shows anelongate body 10 in which the distal end is folded or “looped” to create a loop 14 (FIG. 1B ) at the distal end of the medical device. The suture as shown inFIGS. 1 and 2 further includestransition area 16 and anchors which will be described in further detail below. An anchoring suture may also contain an integral loop as shown inFIG. 3 , wherein the loop portion may be molded. In alternate embodiments, such asFIG. 2 , anchoring sutures may comprise two components which are fixed or fitted together in a fashion as to create the anchoring suture. For example, theelongate body 10 may include a female component while theloop 14 may include a male component and the two components may be fitted together to create a final product. One skilled in the art can envision other manufacturing processes in which to create integral loops and medical devices with integral and non-integral loops. - Another embodiment of the anchoring suture of the present disclosure is shown in
FIG. 3 and is designated generally byreference numeral 2.Suture 2 has anelongate body 10, a proximal portion ofelongate body 10 terminating in afree end 11, and a distal portion of theelongate body 10 which forms, transitions into, or terminates in aloop 14. As shown inFIG. 3 , thefree end 11 further comprises aneedle 12. Theelongate body 10 has a diameter “x” and, in preferred embodiments, theelongate body 10 is generally elliptical in transverse cross-section. The distal end ofelongate body 10 extends into aloop 14, bifurcating at transition area 16 (FIGS. 3 and 3 a).Loop 14 includes twobranches elongate body 10. In preferred embodiments,sections FIG. 3 , theloop 14 may be integral with theelongate body 10 of thesuture 2. In alternate embodiments, theloop 14 may be a separate component prior to assembly (FIGS. 1 and 2 ), and during assembly theloop 14 may be attached to theelongate body 10. Theloop 14 has a generally arcuate surface, and each branch (14 a and 14 b) has an independent diameter “y”, of which 14 a and 14 b may be of similar or different diameters. The loop may be of any shape including circular, oval, polygonal. - Furthermore, anchoring suture of
FIG. 3 includes a first plurality ofanchors 18 disposed along a surface of theloop 14.Anchors 18 a are disposed along surface ofbranch 14 a and anchors 18 b are disposed alongbranch 14 b. Additionally,segment 14 c is used to designate a loop segment in which barbs are absent. In the illustrated embodiment, anchors 18 are locatedadjacent transition area 16 ofelongate body 10 and anchoringloop 14. Furthermore, the first plurality ofanchors 18 is oriented such that movement of the anchoringloop 14 towards the proximal end is limited. As shown inFIG. 3 , anchors 18 are oriented towardstransition area 16 to prevent movement of anchoringloop 14 through tissue. In embodiments shown, anchors 18 are integral to the anchoringloop 14. - It will be understood that
FIG. 4 is a generally similar toFIG. 3 and therefore all numerals and descriptions which are the same inFIG. 3 are designated with the prime mark and have some differences.FIG. 4 shows an alternate embodiment of an anchoringsuture 2′ in which a second plurality ofanchors 22 is disposed along theelongate body 10′. The second plurality ofanchors 22 extends in the second direction which is different from a first direction of the first plurality of anchors. In the embodiment shown, the first plurality ofanchors 18′ are disposed along a loop surface and extend in the first direction, generally towardstransition area 16′ of the anchoringsuture 2′. The second plurality ofanchors 22 extend in a second direction, towards theloop 14′, with respect to longitudinal axis A of theelongate body 10. As shown inFIG. 4 . the first plurality ofanchors 18′ and the second plurality ofanchors 22 extend in directions substantially opposite to one another. The second plurality ofanchors 22 permits movement of theelongate body 10′ in the direction of the leading or proximal end while preventing movement of theelongate body 10′ towards the loop end. - In the alternate embodiment shown in
FIG. 5 , anchoringsuture 30 includes acompound barb 26 having aninner surface 30 including a first angle α, disposed at a first orientation relative to a longitudinal axis “A′” of the elongate body and a second angle β having a secondinner surface 32, disposed at a second orientation relative to a longitudinal axis b of the elongate body. The anchoring suture may optionally include a third orientation (not shown). In the embodiment shown, the first, second and third orientations are each disposed at different angles with respect to the longitudinal axis. In some embodiments, the anchoring suture may include a staggered arrangement of large or small barbs. In other embodiments, an anchoring suture may have a random configuration of both large and small barbs. It will be understood that the embodiment shown inFIG. 5 is generally similar toFIGS. 3 and 4 , but has a different geometry for the barbs. In alternate embodiments, the above-mentioned compound barb geometry may also be present on the anchoring loop (not shown). - The surface area of the plurality of anchors can also vary. For example, fuller-tipped anchors can be made of varying sizes designed for specific surgical applications. When joining fat and relatively soft tissues, larger anchors may be desired, whereas smaller anchors may be more suitable for collagen-dense tissues. In some embodiments (
FIG. 4 ), a combination of large and small anchors within the same structure may be beneficial, for example when a fiber is used in tissue repair with differing layer structures. Use of the combination of large and small anchors with the same fiber wherein anchor sizes are customized for each tissue layer will ensure maximum holding properties. - Another embodiment of an anchoring device is shown in
FIG. 6 . The anchoringdevice 40 includes aneedle 42 at aproximal end 41 of the device. The device bifurcates at atransition area 45, and a distal portion of the device terminates in ananchoring loop 49. The anchoringloop 49 includes twobranches proximal end 47 of the anchoringloop 49. The anchoringloop 49 has a generally arcuate surface,branches anchors 48 are located adjacent thetransition area 45. Furthermore, the first plurality ofanchors 48 is oriented such that movement of the anchoringloop 49 in tissue, in a direction towards thedistal end 43 of the device, is limited. As illustrated inFIG. 6 , the device may have anelongate body 44 that is shorter in longitudinal length as compared to the anchoringloop 49. The two branches of the loop may be advanced through a single needle penetration point and pulled through tissue; the method of which will be described in detail later. -
FIG. 7 illustrates an alternate embodiment of ananchoring device 50 which may be used in combination with a mechanical suturing device such as an Endo Stitch™ suturing device commercially available from Tyco Healthcare Group LP. Anchoringdevice 50 includes aneedle 52 which is compatible with a mechanical suturing device such as an Endo Stitch™ suturing device. Theproximal portion 51 of the anchoring suture includes anelongate body 54, and thedistal portion 55 of the suture terminates in aloop 59. Theloop 59 includes twobranches barbs 58 on a surface thereof. In other embodiments, a plurality of barbs may only be on a surface of at least one branch or a portion of the anchoring device. Theloop 59 also includes an unbarbeddistal portion 56 c. The loop further includes anend effector 57 which limits movement of the anchoring device through tissue. In some embodiments, the end effector is located on the unbarbeddistal portion 56 c of the loop (FIG. 7 ). As illustrated, theend effector 57 is a bulk (large mass) of suture material, which is generally “T”-shaped and in the current embodiment, the end effector is welded to theloop 59. - This disclosure contemplates different end effectors and non-limiting alternate embodiments are illustrated in
FIGS. 8A , 8B and 8C. InFIG. 8A an end effector is illustrated as a second plurality ofbarbs 60 which are oriented such that movement of an end portion of theloop 63 through tissue towards a proximal end of the anchoring suture is limited. In this embodiment, a first plurality ofbarbs 62 located at a proximal portion of theloop 63 are shown oriented in a generally opposite direction to a second plurality ofbarbs 60, which are located at a distal portion ofloop 63. In another embodiment,FIG. 8B , the end effector is abead 65 of a polymeric material. In some embodiments, the bead may of a similar material to the anchoring loop and in alternate embodiments; the bead may be comprised of a different material than the anchoring loop. In some embodiments, such asFIGS. 8A and 8B , the end effector is integral with the loop. In yet other embodiments, the end effector may be a separate device such as a pledget or buttress. As illustrated inFIG. 8C , the end effector is apledget 67 formed on or otherwise attached to the loop. In this embodiment, prior to creating a loop, a suture may penetrate thepledget 67 and a length of the suture may be pulled through the pledget. It should be noted that once the pledget has been moved across a portion ofbarbs 68 projecting from the suture surface, the barbs will prevent the pledget from disengaging the suture and the barbs will retain the pledget in place on the suture. Next, a loop may be created via various means including those described above, and thepledget 67 may be positioned at a distal most point of the anchoring loop. It should be understood that end effectors are not limited to those structures described herein and one skilled in the art may contemplate other shapes and devices which may be used for a similar purpose. End effectors may be constructed using methods within the purview of those skilled in the art, including but not limited to glues, adhesives, lasers, ultrasonic or heat welding, molding, overmolding and the like. Any of the suture materials and structures discussed above may be used to form the anchoring devices discussed herein. - As used herein, the term “tissue” includes, but is not limited to, tissues such as skin, fat, fascia, bones, muscles, tendons, ligaments, organs, nerves, and blood vessels. Also used herein, the term “wound” includes, but is not limited to, a surgical incision, cut, laceration or severed tissue in human or animal skin or other human or animal bodily tissue.
- Tissue may be sutured by inserting proximal portion of an anchoring suture into tissue at a first section and advancing the proximal portion of the suture through a second section of the tissue, and exiting tissue at an exit point. The suture is pulled through the exit point until the first plurality of barbs on the anchoring loop engages tissue and resists movement in direction of needle advancement, thus preventing further advancement of anchoring loop through tissue. The proximal portion of the suture may optionally be inserted through the segment of the loop remaining outside the body tissue for enhanced fixation.
FIGS. 9A and 9B show the embodiment ofFIG. 4 , where anunbarbed loop segment 14 c′ remains exterior to the wound site (or external to skin in dermal closure) due to theanchors 18 a′ and 18 b′ and lack of anchors onsegment 14 c′. It should be understood that all embodiments described herein can be used in a similar fashion. Upon exit of tissue, needle and proximal end of suture may be passed through segment of loop which remains exterior to wound site to secure suture in place. User may then continue suturing wound, entering and exiting tissue until wound site is closed (or implant attached). -
FIGS. 10A and 10B illustrate the embodiment ofFIG. 8C in tissue. Tissue may be secured in a similar manner as described above, by inserting a proximal portion of the anchoring device into tissue at a first section and advancing the proximal portion of the anchoring device, including a proximal portion of the loop, through a second section of the tissue, and exiting tissue at an exit point. In the embodiments described inFIGS. 6 , 7, 8A, 8B, and 8C once the needle is advanced through tissue, the remainder of the suture follows including the two branches of the loop. More specifically, the two branches of the loop are advanced through a needle penetration point (or points through which the needle and elongate body have passed).FIG. 10A illustrates a first position of the embodiment of an anchoring device as described inFIG. 8C . As illustrated, proximal portion ofsuture 70 andproximal portion 71 ofloop 72, including twobranches branches FIG. 10B shows the embodiment ofFIG. 8C in a second position. Once the anchoring suture has been further advanced through tissue, thepledget 67 prevents any further movement of the distal loop portion through tissue. It should be understood that other embodiments of end effectors and shown and described would function in a manner similar to the embodiment described with respect toFIGS. 10A and 10B . It should also be understood that anchoring sutures without end effectors may also be inserted and advanced through tissue in a similar manner. -
FIG. 11A shows the prior art in which anoversized needle 80 penetrates tissue, and leaves a tissue penetration point (82 a and 82 b) that asingle suture strand 84 may not fill.FIG. 11B shows one embodiment of the current disclosure in which anoversized needle 90 penetrates tissue and the two branches (94 a and 94 b) of theanchoring device 94 can better fill theneedle penetration point 92. The two branches of the loop in combination with the barbs allow an increase in tissue holding strength which may be desirable in certain applications. - In order to facilitate needle attachment to an anchoring suture or device of the present disclosure, conventional tipping agents can be applied to the braid. Two tipped ends of the fiber may be desirable for attaching a needle to each end of the fiber to provide a so-called double armed suture. The needle attachment can be made by any conventional method such as crimping, swaging, etc, as is known within the purview of those skilled in the art. Alternatively, a reduced diameter may be provided at the end of the suture to be inserted into the drilled end of a needle. To provide a reduced diameter, the suture may by machined using any technique within the purview of those skilled in the art, such as cutting, grinding, laser machining or the like.
- Anchoring devices, including anchoring sutures of the present disclosure may be employed in medical devices, drug delivery devices and cell growth substrates. Examples of suitable medical devices and/or surgical devices employing the anchoring sutures may include, but are not limited to meshes, wound dressings, bandages, drug delivery devices, anastomosis rings, stents, grafts, catheter systems, soft tissue repair and augmentation devices, scaffolds, buttresses, lap bands, tapes, anchors, ribbons, orthopedic devices, tissue engineering scaffolds, various cell growth substrates, and other implantable devices. In some embodiments, devices of the present disclosure may be knitted or woven with other fibers, either absorbable or non-absorbable, to form surgical devices. The anchoring devices and/or sutures also can be made into meshes or non-woven materials to form fabrics, such as matted fabrics and felts.
- Additionally, anchoring devices of the present disclosure may be packaged using materials known to those within the purview of those skilled in the art, including foil and various plastics (e.g. polyethylene), which may provide a moisture barrier.
- Once the anchoring device is constructed, it can be sterilized by any means within the purview of those skilled in the art including but not limited to ethylene oxide, electron beam (e-beam), gamma irradiation, autoclaving, and the like.
- Distal end of Maxon™ suture is folded towards elongate body to create a loop, and suture (loop) is then placed in an ultrasonic welding apparatus, where loop is welded closed. Suture is then affixed to an ultrasonic cutting apparatus to create barbs. Elongate body and anchoring loop of anchoring suture is cut via ultrasonic blades at various angles.
- Distal end of Surgipro™ suture is folded towards elongate body to create loop and glue is placed on elongate body and distal suture end is folded over and attached to elongate body, creating a fixed loop. Suture is then affixed to a cutting apparatus and anchoring suture is cut at various angles using a knife. Anchoring suture is then coated with a chemotherapeutic agent using solvent casting.
- Distal end of Maxon™ suture is folded towards elongate body to create a loop, and suture (loop) is then placed in an ultrasonic welding apparatus, where loop is welded closed. The ultrasonic welding apparatus is then used to weld a distal end of the loop into a generally “T”-shape, creating an end effector. Suture is next affixed to an ultrasonic cutting apparatus to create barbs. Elongate body and a proximal portion of the anchoring loop of anchoring suture is cut via ultrasonic blades at various angles.
- It should be noted that the present disclosure is not limited to wound closure and contemplates other procedures such as cosmetic and orthopedic procedures. Additionally, the above description contains many specifics; these specifics should not be construed as limitations on the scope of the disclosure herein but merely as exemplifications of particularly useful embodiments thereof. Those skilled in the art will envision many other possibilities within the scope and spirit of the disclosure as defined by the claims appended hereto.
Claims (12)
1-9. (canceled)
10. A medical device comprising:
an elongate body having a proximal portion and a distal portion, the proximal portion of the elongate body terminating in a free end;
the distal portion of the elongate body forming a loop;
the loop including a first plurality of anchors disposed along a surface of the loop; and,
the loop further including at least one end effector.
11. The medical device of claim 10 , wherein the end effector is selected from the group consisting of barb, knot, pledget, and buttress.
12. The medical device of claim 10 , wherein the end effector is a bulk of a material configured and dimensioned to limit movement of a distal segment of the loop in a proximal direction through tissue.
13. The medical device of claim 10 , wherein the end effector is integral with the loop.
14. The medical device of claim 10 , wherein the end effector is separate device which is secured to the loop.
15. The medical device of claim 10 , wherein the end effector limits movement of at least a portion of the loop through tissue such that a segment of the loop remains outside a body tissue.
16. The medical device of claim 10 , wherein the end effector engages tissue to prevent movement of the loop in a proximal direction.
17. The medical device of claim 10 , further comprising a needle secured to a proximal portion of the elongate body.
18. The medical device of claim 10 , wherein the two branches of the suture further include barbs on a surface thereof.
19. The medical device of claim 18 , wherein the barbs secure the two branches in body tissue.
20. A method for securing tissue, the method comprising the steps of:
providing the medical device of claim 10 ,
inserting a proximal portion of the medical device into tissue,
pulling the two branches of the loop through tissue such that the two branches are simultaneously pulled through a penetration point; and,
advancing the proximal portion of the loop through tissue such that the end effector limits movement of the distal portion of the loop through the tissue.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/568,216 US20150119933A1 (en) | 2008-04-01 | 2014-12-12 | Anchoring device |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4130208P | 2008-04-01 | 2008-04-01 | |
US12/362,002 US10376261B2 (en) | 2008-04-01 | 2009-01-29 | Anchoring suture |
US12/416,421 US8932327B2 (en) | 2008-04-01 | 2009-04-01 | Anchoring device |
US14/568,216 US20150119933A1 (en) | 2008-04-01 | 2014-12-12 | Anchoring device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/416,421 Division US8932327B2 (en) | 2008-04-01 | 2009-04-01 | Anchoring device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150119933A1 true US20150119933A1 (en) | 2015-04-30 |
Family
ID=41118312
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/416,421 Active 2031-05-01 US8932327B2 (en) | 2008-04-01 | 2009-04-01 | Anchoring device |
US14/568,216 Abandoned US20150119933A1 (en) | 2008-04-01 | 2014-12-12 | Anchoring device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/416,421 Active 2031-05-01 US8932327B2 (en) | 2008-04-01 | 2009-04-01 | Anchoring device |
Country Status (1)
Country | Link |
---|---|
US (2) | US8932327B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11224419B2 (en) * | 2019-06-28 | 2022-01-18 | Cilag Gmbh International | Bi-directional barbed suture with tailored suture segments |
US11458004B2 (en) | 2017-10-19 | 2022-10-04 | C.R. Bard, Inc. | Self-gripping hernia prosthesis |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8795332B2 (en) | 2002-09-30 | 2014-08-05 | Ethicon, Inc. | Barbed sutures |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5931855A (en) | 1997-05-21 | 1999-08-03 | Frank Hoffman | Surgical methods using one-way suture |
US7056331B2 (en) | 2001-06-29 | 2006-06-06 | Quill Medical, Inc. | Suture method |
US6848152B2 (en) | 2001-08-31 | 2005-02-01 | Quill Medical, Inc. | Method of forming barbs on a suture and apparatus for performing same |
US6773450B2 (en) | 2002-08-09 | 2004-08-10 | Quill Medical, Inc. | Suture anchor and method |
US8100940B2 (en) | 2002-09-30 | 2012-01-24 | Quill Medical, Inc. | Barb configurations for barbed sutures |
US20040088003A1 (en) | 2002-09-30 | 2004-05-06 | Leung Jeffrey C. | Barbed suture in combination with surgical needle |
US7624487B2 (en) | 2003-05-13 | 2009-12-01 | Quill Medical, Inc. | Apparatus and method for forming barbs on a suture |
US8100923B2 (en) | 2003-09-15 | 2012-01-24 | Abbott Laboratories | Suture locking device and methods |
ES2638301T3 (en) | 2004-05-14 | 2017-10-19 | Ethicon Llc | Suture devices |
US20080255612A1 (en) | 2007-04-13 | 2008-10-16 | Angiotech Pharmaceuticals, Inc. | Self-retaining systems for surgical procedures |
ES2488406T3 (en) | 2007-09-27 | 2014-08-27 | Ethicon Llc | Self-retaining sutures that include tissue retention elements with enhanced strength |
US8916077B1 (en) | 2007-12-19 | 2014-12-23 | Ethicon, Inc. | Self-retaining sutures with retainers formed from molten material |
CN101902974B (en) | 2007-12-19 | 2013-10-30 | 伊西康有限责任公司 | Self-retaining sutures with heat-contact mediated retainers |
US8118834B1 (en) | 2007-12-20 | 2012-02-21 | Angiotech Pharmaceuticals, Inc. | Composite self-retaining sutures and method |
WO2009097556A2 (en) | 2008-01-30 | 2009-08-06 | Angiotech Pharmaceuticals, Inc. | Appartaus and method for forming self-retaining sutures |
US8615856B1 (en) | 2008-01-30 | 2013-12-31 | Ethicon, Inc. | Apparatus and method for forming self-retaining sutures |
US8273105B2 (en) | 2008-02-20 | 2012-09-25 | Tyco Healthcare Group Lp | Compound barb medical device and method |
BRPI0907787B8 (en) | 2008-02-21 | 2021-06-22 | Angiotech Pharm Inc | method for forming a self-retaining suture and apparatus for raising the retainers in a suture to a desired angle |
US8216273B1 (en) | 2008-02-25 | 2012-07-10 | Ethicon, Inc. | Self-retainers with supporting structures on a suture |
US8641732B1 (en) | 2008-02-26 | 2014-02-04 | Ethicon, Inc. | Self-retaining suture with variable dimension filament and method |
US9358002B2 (en) | 2008-04-01 | 2016-06-07 | Covidien Lp | Anchoring device |
ES2709687T3 (en) | 2008-04-15 | 2019-04-17 | Ethicon Llc | Self-retaining sutures with bi-directional retainers or unidirectional retainers |
EP2279013B1 (en) * | 2008-04-24 | 2015-08-05 | Ethicon, LLC | Shape-memory self-retaining sutures, methods of manufacture, and methods of use |
SG196767A1 (en) | 2008-11-03 | 2014-02-13 | Ethicon Llc | Length of self-retaining suture and method and device for using the same |
US9204965B2 (en) | 2009-01-14 | 2015-12-08 | Lc Therapeutics, Inc. | Synthetic chord |
WO2011090628A2 (en) | 2009-12-29 | 2011-07-28 | Angiotech Pharmaceuticals, Inc. | Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods |
CA2825186A1 (en) | 2010-01-20 | 2011-07-28 | Michael P. Whitman | Tissue repair implant and delivery device and method |
US10743854B2 (en) | 2010-01-20 | 2020-08-18 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10058314B2 (en) | 2010-01-20 | 2018-08-28 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US9980708B2 (en) | 2010-01-20 | 2018-05-29 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10959840B2 (en) | 2010-01-20 | 2021-03-30 | Micro Interventional Devices, Inc. | Systems and methods for affixing a prosthesis to tissue |
CN104706390B (en) | 2010-05-04 | 2017-05-17 | 伊西康有限责任公司 | Laser cutting system and methods for creating self-retaining sutures |
ES2615229T3 (en) | 2010-06-11 | 2017-06-06 | Ethicon, Llc | Suture dispensing tools for endoscopic and robot-assisted surgery and procedures |
IT1400838B1 (en) * | 2010-07-08 | 2013-07-02 | Assut Europ S P A | SUTURE WIRE. |
JP2014504894A (en) | 2010-11-03 | 2014-02-27 | アンジオテック ファーマシューティカルズ, インコーポレイテッド | Indwelling suture material for eluting drug and method related thereto |
WO2012064902A2 (en) | 2010-11-09 | 2012-05-18 | Angiotech Pharmaceuticals, Inc. | Emergency self-retaining sutures and packaging |
US9149265B2 (en) | 2011-02-26 | 2015-10-06 | Abbott Cardiovascular Systems, Inc. | Hinged tissue support device |
KR101132841B1 (en) * | 2011-03-07 | 2012-04-02 | 김영재 | A suture |
WO2012129534A2 (en) | 2011-03-23 | 2012-09-27 | Angiotech Pharmaceuticals, Inc. | Self-retaining variable loop sutures |
US20120253388A1 (en) * | 2011-03-29 | 2012-10-04 | Tyco Healthcare Group Lp | Anchor Member For Looped Sutures |
US20130172931A1 (en) | 2011-06-06 | 2013-07-04 | Jeffrey M. Gross | Methods and devices for soft palate tissue elevation procedures |
US9055932B2 (en) | 2011-08-26 | 2015-06-16 | Abbott Cardiovascular Systems, Inc. | Suture fastener combination device |
US10973513B2 (en) | 2011-09-29 | 2021-04-13 | Ethicon, Llc | Barbed suture having increased holding strength |
US20130231699A1 (en) * | 2012-02-20 | 2013-09-05 | Dr7 Innovations, Llc | Locking suture |
WO2013126130A1 (en) * | 2012-02-23 | 2013-08-29 | Northwestern University | Improved suture |
US9138214B2 (en) * | 2012-03-02 | 2015-09-22 | Abbott Cardiovascular Systems, Inc. | Suture securing systems, devices and methods |
EP2887886B1 (en) * | 2012-08-23 | 2020-04-22 | Covidien LP | Tissue fixation device |
US11672529B2 (en) | 2012-09-17 | 2023-06-13 | Cilag Gmbh International | Barbed sutures having contoured barbs that facilitate passage through tissue and increase holding strength |
US9144425B2 (en) * | 2012-10-03 | 2015-09-29 | Lee D. Kaplan | Suture for soft tissue repair |
US9724085B2 (en) * | 2012-10-03 | 2017-08-08 | Lee D. Kaplan | Suture for soft tissue repair |
US9486132B2 (en) | 2013-01-17 | 2016-11-08 | Abbott Cardiovascular Systems, Inc. | Access device for accessing tissue |
KR102274864B1 (en) * | 2013-02-15 | 2021-07-08 | 서지매틱스, 아이엔씨. | Medical fastening device |
CN105307581A (en) * | 2013-05-08 | 2016-02-03 | 森特里心脏股份有限公司 | Tissue ligation devices and methods therefor |
JP6505673B2 (en) * | 2013-09-26 | 2019-04-24 | サージマティクス, インコーポレーテッドSurgimatix, Inc. | Laparoscopic suture device with automatic loading mechanism and suture element capture |
US9533446B2 (en) | 2014-10-21 | 2017-01-03 | Ethicon, Inc. | Suture having a restraining element at an end and method and use thereof |
EP3209219B1 (en) | 2014-10-21 | 2020-06-10 | Ethicon LLC | Suture having a restraining element at an end and method of forming a suture |
TW201618722A (en) * | 2014-10-28 | 2016-06-01 | 特羅凱爾有限公司 | Fascia closure device and method |
US9795378B2 (en) | 2014-10-31 | 2017-10-24 | Ethicon, Inc. | Method for approximating wounds |
WO2016154609A1 (en) * | 2015-03-26 | 2016-09-29 | Central Park Diagnostics, Inc. | Suture delivery device, and suture, for facilitating fibrosis and healing |
US10188379B2 (en) | 2015-09-03 | 2019-01-29 | Ethicon Llc | End effector for wound closure device |
US10336001B2 (en) | 2015-09-04 | 2019-07-02 | Ethicon, Inc. | End effector for wound closure device |
USD780918S1 (en) | 2015-09-04 | 2017-03-07 | Ethicon, Inc. | Welded end effector |
WO2017156259A1 (en) | 2016-03-10 | 2017-09-14 | Lc Therapeutics, Inc. | Synthetic chord for cardiac valve repair applications |
US10524776B2 (en) | 2016-11-08 | 2020-01-07 | Arthrex, Inc. | Soft suture anchor assembly with barbed suture and attached tissue fixation disk |
US11272924B2 (en) | 2018-07-18 | 2022-03-15 | Arthrex, Inc. | Knotless closure sutures and methods of tissue fixation |
US11439383B2 (en) | 2019-08-20 | 2022-09-13 | Abbott Cardiovascular Systems, Inc. | Self locking suture and self locking suture mediated closure device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643295A (en) * | 1994-12-29 | 1997-07-01 | Yoon; Inbae | Methods and apparatus for suturing tissue |
US20080281357A1 (en) * | 2007-05-09 | 2008-11-13 | An-Min Jason Sung | Looped tissue-grasping device |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657056A (en) * | 1967-12-11 | 1972-04-18 | Ultrasonic Systems | Ultrasonic suturing apparatus |
US4024871A (en) * | 1975-07-23 | 1977-05-24 | Ethicon, Inc. | Antimicrobial sutures |
US5226912A (en) * | 1987-08-26 | 1993-07-13 | United States Surgical Corporation | Combined surgical needle-braided suture device |
US5306289A (en) * | 1987-08-26 | 1994-04-26 | United States Surgical Corporation | Braided suture of improved characteristics |
US5261886A (en) * | 1987-08-26 | 1993-11-16 | United States Surgical Corporation | Cabled core and braided suture made therefrom |
US5019093A (en) * | 1989-04-28 | 1991-05-28 | United States Surgical Corporation | Braided suture |
US5133738A (en) * | 1989-09-27 | 1992-07-28 | United States Surgical Corporation | Combined surgical needle-spiroid braided suture device |
US5123913A (en) * | 1989-11-27 | 1992-06-23 | Wilk Peter J | Suture device |
US5059213A (en) * | 1990-03-26 | 1991-10-22 | United States Surgical Corporation | Spiroid braided suture |
US5181923A (en) * | 1990-03-26 | 1993-01-26 | United States Surgical Corporation | Spiroid braided suture |
US5236563A (en) * | 1990-06-18 | 1993-08-17 | Advanced Surface Technology Inc. | Surface-modified bioabsorbables |
US5370031A (en) * | 1990-08-17 | 1994-12-06 | United States Surgical Corporation | Braider apparatus with improved bobbin holder |
CA2048464A1 (en) * | 1990-08-17 | 1992-02-18 | Michael P. Chesterfield | Apparatus and method for producing braided suture products |
CA2704193C (en) * | 1990-12-13 | 2011-06-07 | United States Surgical Corporation | Method and apparatus for tipping sutures |
US5259846A (en) * | 1991-01-07 | 1993-11-09 | United States Surgical Corporation | Loop threaded combined surgical needle-suture device |
CA2059245C (en) | 1991-02-08 | 2004-07-06 | Michael P. Chesterfield | Method and apparatus for calendering and coating/filling sutures |
US5318575A (en) * | 1992-02-03 | 1994-06-07 | United States Surgical Corporation | Method of using a surgical repair suture product |
US5417700A (en) * | 1992-03-30 | 1995-05-23 | Thomas D. Egan | Automatic suturing and ligating device |
US5383883A (en) * | 1992-06-07 | 1995-01-24 | Wilk; Peter J. | Method for ultrasonically applying a surgical device |
US8795332B2 (en) * | 2002-09-30 | 2014-08-05 | Ethicon, Inc. | Barbed sutures |
US5342376A (en) * | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US6241747B1 (en) * | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5500000A (en) | 1993-07-01 | 1996-03-19 | United States Surgical Corporation | Soft tissue repair system and method |
CA2133686C (en) | 1993-10-08 | 2006-10-03 | Elliott A. Gruskin | Infection-resistant surgical devices and methods of making them |
JPH10502270A (en) * | 1994-06-28 | 1998-03-03 | クロージャー メディカル コーポレイション | Biocompatible monomer and polymer compositions with pH modification |
US5582616A (en) * | 1994-08-05 | 1996-12-10 | Origin Medsystems, Inc. | Surgical helical fastener with applicator |
US5772640A (en) * | 1996-01-05 | 1998-06-30 | The Trustees Of Columbia University Of The City Of New York | Triclosan-containing medical devices |
CN1091453C (en) | 1995-08-29 | 2002-09-25 | 埃克森美孚化学专利公司 | Radiation tolerant polypropylene and its useful articles |
US5667528A (en) * | 1995-11-22 | 1997-09-16 | United States Surgical Corporation | Braided suture surgical incision member attachment |
US6063105A (en) * | 1996-06-18 | 2000-05-16 | United States Surgical | Medical devices fabricated from elastomeric alpha-olefins |
US5716376A (en) | 1996-06-28 | 1998-02-10 | United States Surgical Corporation | Absorbable mixture and coatings for surgical articles fabricated therefrom |
DE19628909C2 (en) * | 1996-07-18 | 1999-11-18 | Ruesch Willy Ag | Closure |
US5830234A (en) * | 1997-04-04 | 1998-11-03 | Alto Development Corporation | Method for double wire sternotomy suture |
US5968077A (en) * | 1997-04-04 | 1999-10-19 | Alto Development Corporation | Double wire sternothomy suture |
US5931855A (en) * | 1997-05-21 | 1999-08-03 | Frank Hoffman | Surgical methods using one-way suture |
US6692499B2 (en) * | 1997-07-02 | 2004-02-17 | Linvatec Biomaterials Oy | Surgical fastener for tissue treatment |
US20070021780A1 (en) * | 1997-08-28 | 2007-01-25 | Francis Harrington | Multicomponent fused suture loop and apparatus for making same |
US6286746B1 (en) * | 1997-08-28 | 2001-09-11 | Axya Medical, Inc. | Fused loop of filamentous material and apparatus for making same |
US5893880A (en) * | 1997-08-28 | 1999-04-13 | Axya Medical Inc. | Fused loop filamentous material |
US6217591B1 (en) * | 1997-08-28 | 2001-04-17 | Axya Medical, Inc. | Suture fastening device |
US6203564B1 (en) * | 1998-02-26 | 2001-03-20 | United States Surgical | Braided polyester suture and implantable medical device |
US5964765A (en) * | 1998-04-16 | 1999-10-12 | Axya Medical, Inc. | Soft tissue fixation device |
US6165202A (en) * | 1998-07-06 | 2000-12-26 | United States Surgical Corporation | Absorbable polymers and surgical articles fabricated therefrom |
US6174324B1 (en) * | 1998-07-13 | 2001-01-16 | Axya Medical, Inc. | Suture guide and fastener |
US6235869B1 (en) * | 1998-10-20 | 2001-05-22 | United States Surgical Corporation | Absorbable polymers and surgical articles fabricated therefrom |
US6488690B1 (en) * | 1999-03-17 | 2002-12-03 | John K. Morris | Suture knot sealing instruments and methods of using the same |
US6224579B1 (en) | 1999-03-31 | 2001-05-01 | The Trustees Of Columbia University In The City Of New York | Triclosan and silver compound containing medical devices |
US6991643B2 (en) * | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
JP2001198131A (en) | 2000-01-18 | 2001-07-24 | Matsuda Ika Kk | Suture for operation having ring |
US20040010275A1 (en) * | 2000-05-19 | 2004-01-15 | Daniel Jacobs | Multi-point tissue tension distribution device and method, a custom-fittable variation |
US6620846B1 (en) * | 2000-08-02 | 2003-09-16 | Closure Medical Corporation | Absorbable adhesive compositions |
EP1309279A4 (en) * | 2000-08-17 | 2008-04-09 | Tyco Healthcare | Sutures and coatings made from therapeutic absorbable glass |
US6923824B2 (en) * | 2000-09-12 | 2005-08-02 | Axya Medical, Inc. | Apparatus and method for securing suture to bone |
US6506197B1 (en) * | 2000-11-15 | 2003-01-14 | Ethicon, Inc. | Surgical method for affixing a valve to a heart using a looped suture combination |
CA2441892A1 (en) * | 2001-03-26 | 2002-10-03 | Tyco Healthcare Group Lp | Polyolefin sutures having improved processing and handling characteristics |
US7056331B2 (en) * | 2001-06-29 | 2006-06-06 | Quill Medical, Inc. | Suture method |
US6599310B2 (en) * | 2001-06-29 | 2003-07-29 | Quill Medical, Inc. | Suture method |
US6848152B2 (en) * | 2001-08-31 | 2005-02-01 | Quill Medical, Inc. | Method of forming barbs on a suture and apparatus for performing same |
US20030097148A1 (en) * | 2001-11-20 | 2003-05-22 | Tero Valimaa | Tissue fastener |
US20030149447A1 (en) * | 2002-02-01 | 2003-08-07 | Morency Steven David | Barbed surgical suture |
US6773450B2 (en) * | 2002-08-09 | 2004-08-10 | Quill Medical, Inc. | Suture anchor and method |
US20040087974A1 (en) * | 2002-09-16 | 2004-05-06 | Bittar Edward S. | Suture welding device and method of welding |
US8100940B2 (en) * | 2002-09-30 | 2012-01-24 | Quill Medical, Inc. | Barb configurations for barbed sutures |
US20040088003A1 (en) | 2002-09-30 | 2004-05-06 | Leung Jeffrey C. | Barbed suture in combination with surgical needle |
DE10254215B4 (en) | 2002-11-20 | 2014-10-09 | Johnson & Johnson Medical Gmbh | Surgical implant |
AU2003293347A1 (en) | 2002-12-13 | 2004-07-09 | Tyco Healthcare Group Lp | Antimicrobial fatty acid containing suture coating |
US20040122451A1 (en) * | 2002-12-23 | 2004-06-24 | Wood Timothy J. | Method and device for closing and fusing suture loops |
CA2513983C (en) | 2003-01-24 | 2012-12-18 | Tyco Healthcare Group Lp | Bioabsorbable composition and coatings including same |
US7021316B2 (en) * | 2003-08-07 | 2006-04-04 | Tools For Surgery, Llc | Device and method for tacking a prosthetic screen |
EP1718700B8 (en) | 2004-02-12 | 2012-10-03 | ExxonMobil Chemical Patents Inc. | Plasticized polyolefin compositions |
US20050209639A1 (en) * | 2004-03-08 | 2005-09-22 | Boston Scientific Scimed, Inc. | Fused suture knot |
ES2638301T3 (en) * | 2004-05-14 | 2017-10-19 | Ethicon Llc | Suture devices |
CA2526541C (en) | 2004-12-01 | 2013-09-03 | Tyco Healthcare Group Lp | Novel biomaterial drug delivery and surface modification compositions |
DE102005004318A1 (en) | 2005-01-31 | 2006-08-10 | Ethicon Gmbh | Surgical seam system |
US7736331B2 (en) * | 2005-03-11 | 2010-06-15 | Merit Medical Systems, Inc. | Drainage catheter hub with welded suture and sidewall stylet |
US20070083236A1 (en) * | 2005-06-24 | 2007-04-12 | Smith & Nephew, Inc. | Methods and devices for tissue repair |
US8663277B2 (en) * | 2005-06-29 | 2014-03-04 | Ethicon, Inc. | Braided barbed suture |
US20070224237A1 (en) * | 2006-03-24 | 2007-09-27 | Julia Hwang | Barbed sutures having a therapeutic agent thereon |
DE602006020077D1 (en) | 2006-05-16 | 2011-03-24 | Marlen Andreevich Sulamanidze | SURGICAL SEAM MATERIAL |
US8636767B2 (en) | 2006-10-02 | 2014-01-28 | Micell Technologies, Inc. | Surgical sutures having increased strength |
WO2008107919A1 (en) | 2007-03-07 | 2008-09-12 | Assut Europe S.P.A. | Prosthesis for the treatment of urinary incontinence |
US10376261B2 (en) | 2008-04-01 | 2019-08-13 | Covidien Lp | Anchoring suture |
-
2009
- 2009-04-01 US US12/416,421 patent/US8932327B2/en active Active
-
2014
- 2014-12-12 US US14/568,216 patent/US20150119933A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643295A (en) * | 1994-12-29 | 1997-07-01 | Yoon; Inbae | Methods and apparatus for suturing tissue |
US20080281357A1 (en) * | 2007-05-09 | 2008-11-13 | An-Min Jason Sung | Looped tissue-grasping device |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11458004B2 (en) | 2017-10-19 | 2022-10-04 | C.R. Bard, Inc. | Self-gripping hernia prosthesis |
US11224419B2 (en) * | 2019-06-28 | 2022-01-18 | Cilag Gmbh International | Bi-directional barbed suture with tailored suture segments |
Also Published As
Publication number | Publication date |
---|---|
US8932327B2 (en) | 2015-01-13 |
US20090248067A1 (en) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8932327B2 (en) | Anchoring device | |
EP2106752B1 (en) | Anchoring device | |
AU2008237580B2 (en) | Filament-reinforced composite fiber | |
EP2494930B1 (en) | Deployment system for surgical suture | |
JP6396402B2 (en) | Self-holding variable loop suture | |
KR101851119B1 (en) | Surface texture configuration for self-retaining sutures and methods for forming same | |
JP2011240133A (en) | Anchoring device | |
US20220071621A1 (en) | Tapered transition portion for suture needles | |
US20220071625A1 (en) | Curved suture needles having a non-smooth profile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TYCO HEALTHCARE GROUP LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KOSA, TIMOTHY D.;MAIORINO, NICHOLAS;SIGNING DATES FROM 20090519 TO 20090611;REEL/FRAME:034644/0471 Owner name: COVIDIEN LP, MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:TYCO HEALTHCARE GROUP LP;REEL/FRAME:034730/0035 Effective date: 20120928 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |